• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可推广的疾病遗传结构假说:多态风险基因座。

A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci.

机构信息

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.

出版信息

Hum Mol Genet. 2011 Oct 15;20(R2):R158-62. doi: 10.1093/hmg/ddr358. Epub 2011 Aug 29.

DOI:10.1093/hmg/ddr358
PMID:21875901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179380/
Abstract

The dominant and sometimes competing theories for the aetiology of complex human disease have been the common disease, common variant (CDCV) hypothesis, and the multiple rare variant (MRV) hypothesis. With the advent of genome wide association studies and of second-generation sequencing, we are fortunate in being able to test these ideas. The results to date suggest that these hypotheses are not mutually exclusive. Further, initial evidence suggests that both MRV and CDCV can be true at the same loci, and that other disease-related genetic mechanisms also exist at some of these loci. We propose calling these, pleomorphic risk loci, and discuss here how such loci not only offer understanding of the genetic basis of disease, but also provide mechanistic biological insight into disease processes.

摘要

复杂人类疾病病因的主要理论(有时也是竞争理论)一直是常见疾病常见变异(CDCV)假说和多种罕见变异(MRV)假说。随着全基因组关联研究和第二代测序的出现,我们有幸能够检验这些观点。迄今为止的结果表明,这些假设并非互斥。此外,初步证据表明,MRV 和 CDCV 可以在同一基因座上同时成立,并且在这些基因座的某些位置还存在其他与疾病相关的遗传机制。我们建议将这些称为多态风险基因座,并在此讨论这些基因座不仅提供了对疾病遗传基础的理解,还为疾病过程提供了机制生物学见解。

相似文献

1
A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci.一种可推广的疾病遗传结构假说:多态风险基因座。
Hum Mol Genet. 2011 Oct 15;20(R2):R158-62. doi: 10.1093/hmg/ddr358. Epub 2011 Aug 29.
2
Genome-wide association analysis of imputed rare variants: application to seven common complex diseases.推算的罕见变异的全基因组关联分析:应用于七种常见复杂疾病
Genet Epidemiol. 2012 Dec;36(8):785-96. doi: 10.1002/gepi.21675. Epub 2012 Sep 5.
3
Nanopore sequencing as a novel method of characterising anorexia nervosa risk loci.纳米孔测序作为一种表征神经性厌食症风险基因座的新方法。
BMC Genomics. 2024 Dec 31;25(1):1262. doi: 10.1186/s12864-024-11172-7.
4
The role of genetic variation in the causation of mental illness: an evolution-informed framework.遗传变异在精神疾病发病机制中的作用:一个进化信息框架。
Mol Psychiatry. 2009 Dec;14(12):1072-82. doi: 10.1038/mp.2009.85. Epub 2009 Aug 25.
5
Discovery and implications of polygenicity of common diseases.常见疾病多基因遗传的发现及其意义。
Science. 2021 Sep 24;373(6562):1468-1473. doi: 10.1126/science.abi8206. Epub 2021 Sep 23.
6
Establishing the role of rare coding variants in known Parkinson's disease risk loci.确定罕见编码变异在已知帕金森病风险基因座中的作用。
Neurobiol Aging. 2017 Nov;59:220.e11-220.e18. doi: 10.1016/j.neurobiolaging.2017.07.009. Epub 2017 Aug 2.
7
Common vs. rare allele hypotheses for complex diseases.复杂疾病的常见等位基因与罕见等位基因假说
Curr Opin Genet Dev. 2009 Jun;19(3):212-9. doi: 10.1016/j.gde.2009.04.010. Epub 2009 May 28.
8
Signature of genetic associations in oral cancer.口腔癌中基因关联的特征
Tumour Biol. 2017 Oct;39(10):1010428317725923. doi: 10.1177/1010428317725923.
9
The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease.基于基因的罕见变异方法在检测疾病相关变异以及检验关于复杂疾病的假设方面的能力。
PLoS Genet. 2015 Apr 23;11(4):e1005165. doi: 10.1371/journal.pgen.1005165. eCollection 2015 Apr.
10
Dynamic Bayesian testing of sets of variants in complex diseases.复杂疾病中变异集的动态贝叶斯检验
Genetics. 2014 Nov;198(3):867-78. doi: 10.1534/genetics.114.167403. Epub 2014 Sep 11.

引用本文的文献

1
Genome-wide assessment identifies novel runs of homozygosity linked to Parkinson's disease etiology across diverse ancestral populations.全基因组评估确定了与不同祖先群体中帕金森病病因相关的新的纯合子片段。
medRxiv. 2025 May 22:2025.05.21.25328076. doi: 10.1101/2025.05.21.25328076.
2
Scrutinizing neurodegenerative diseases: decoding the complex genetic architectures through a multi-omics lens.审视神经退行性疾病:通过多组学视角解码复杂的遗传结构
Hum Genomics. 2024 Dec 31;18(1):141. doi: 10.1186/s40246-024-00704-7.
3
How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types.帕金森病相关 LRRK2 突变如何影响不同的中枢神经系统细胞类型。
J Parkinsons Dis. 2024;14(7):1331-1352. doi: 10.3233/JPD-230432.
4
Is T369M not a risk factor for Parkinson's disease in the Swedish population?在瑞典人群中,T369M难道不是帕金森病的一个风险因素吗?
medRxiv. 2024 Mar 16:2024.03.15.24304347. doi: 10.1101/2024.03.15.24304347.
5
Parkinson's Disease is Predominantly a Genetic Disease.帕金森病主要是一种遗传疾病。
J Parkinsons Dis. 2024;14(3):467-482. doi: 10.3233/JPD-230376.
6
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.在非洲和非洲混合人群中与帕金森病相关的遗传风险基因座和因果关系的鉴定:一项全基因组关联研究。
Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23.
7
Large-scale rare variant burden testing in Parkinson's disease.帕金森病的大规模罕见变异负担测试。
Brain. 2023 Nov 2;146(11):4622-4632. doi: 10.1093/brain/awad214.
8
Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson's disease.探索脑铁沉积相关神经退行性变与帕金森病风险之间的遗传和基因组联系。
NPJ Parkinsons Dis. 2023 Apr 6;9(1):54. doi: 10.1038/s41531-023-00496-y.
9
Genetic testing for Parkinson's disease in clinical practice.帕金森病的临床基因检测。
J Neural Transm (Vienna). 2023 Jun;130(6):777-782. doi: 10.1007/s00702-023-02612-x. Epub 2023 Mar 16.
10
Blood based biomarkers for movement disorders.用于运动障碍的基于血液的生物标志物。
Acta Neurol Scand. 2022 Oct;146(4):353-361. doi: 10.1111/ane.13700.

本文引用的文献

1
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.对序列变异进行推断以识别帕金森病的遗传风险:全基因组关联研究的荟萃分析。
Lancet. 2011 Feb 19;377(9766):641-9. doi: 10.1016/S0140-6736(10)62345-8. Epub 2011 Feb 1.
2
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.帕金森病遗传学研究揭示 SNCA 基因上游的额外关联及 17q21 上的多个相关单倍型。
Hum Mol Genet. 2011 Jan 15;20(2):345-53. doi: 10.1093/hmg/ddq469. Epub 2010 Nov 2.
3
Hundreds of variants clustered in genomic loci and biological pathways affect human height.数以百计的变异体聚集在基因组位置和生物途径中,影响人类身高。
Nature. 2010 Oct 14;467(7317):832-8. doi: 10.1038/nature09410. Epub 2010 Sep 29.
4
Biological, clinical and population relevance of 95 loci for blood lipids.95 个与血脂相关的生物学、临床和人群相关性位点。
Nature. 2010 Aug 5;466(7307):707-13. doi: 10.1038/nature09270.
5
Genome-wide association study reveals genetic risk underlying Parkinson's disease.全基因组关联研究揭示帕金森病的遗传风险。
Nat Genet. 2009 Dec;41(12):1308-12. doi: 10.1038/ng.487. Epub 2009 Nov 15.
6
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.帕金森病中葡萄糖脑苷脂酶突变的多中心分析。
N Engl J Med. 2009 Oct 22;361(17):1651-61. doi: 10.1056/NEJMoa0901281.
7
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.全基因组关联位点对人类疾病和性状的潜在病因学及功能影响。
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9362-7. doi: 10.1073/pnas.0903103106. Epub 2009 May 27.
8
Genomewide association studies and human disease.全基因组关联研究与人类疾病
N Engl J Med. 2009 Apr 23;360(17):1759-68. doi: 10.1056/NEJMra0808700. Epub 2009 Apr 15.
9
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.日本帕金森病患者中的LRRK2突变与风险变异
Mov Disord. 2009 May 15;24(7):1034-41. doi: 10.1002/mds.22514.
10
Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes.参与抗病毒反应的基因IFIH1的罕见变异可预防1型糖尿病。
Science. 2009 Apr 17;324(5925):387-9. doi: 10.1126/science.1167728. Epub 2009 Mar 5.